-
Study aim
-
The aim of the study will be determine and compare the effect of curcumin and placebo on recurrence of nasal polyposis in patients undergoing endoscopic sinus surgery
-
Design
-
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 36 patients. The envelope method will be used for randomization.
-
Settings and conduct
-
study will be performed at Besat Hospital in Hamedan on patients with chronic rhinosinusitis and nasal polyps. Patients will undergo functional endoscopic sinus surgery and polypectomy. After surgery, all patients will take Fluticasone spray, Montelukast tablets, and Cefixime 400 mg capsules as prescribed by the doctor.One group will take capsule containing 500 mg of curcumin and the other group will take a capsule containing starch daily/ months orally. Both groups will be examined at the end of the 1, 4 and 6 month post operation in terms of polyp recurrence and pain score.
-
Participants/Inclusion and exclusion criteria
-
The age of 18 to 60 years and suffering from chronic rhinosinusitis comorbidity with nasal polyps are the conditions for entering the study and the history of allergy to curcumin , the presence of immune system disorders and suffering from systemic diseases are the criteria for not entering the study.
-
Intervention groups
-
The first intervention group: after endoscopic surgery of chronic sinusitis and splenectomy, along with routine care, they will take a capsule containing 500 mg of curcumin orally for 2 months.
The second intervention group: after endoscopic surgery of chronic sinusitis and splenectomy, along with routine care, they will take a capsule containing 500 mg of starch orally for 2 months.
-
Main outcome variables
-
Recurrence of nasal polyps, recurrence of sinusitis and changes in pain score caused by chronic sinusitis will be the main outcomes of the study.